|Values are valid only on day of printing.|
Aiding risk prediction of statin-associated myopathy for patients beginning statin therapy, especially simvastatin therapy
Determining a potential genetic effect related to statin intolerance in patients with statin-associated myopathy, especially related to simvastatin
Genotyping patients who prefer not to have venipuncture done
This is a pharmacogenomics test for the SLCO1B1*5 (c.521T>C, p.V174A; rs4149056) allele. Presence of the *5 allele is associated with an increased risk for simvastatin-associated myopathy.
Polymerase Chain Reaction (PCR) 5’-Nuclease End-Point Allelic Discrimination Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)